Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,628 | -62,106 | -117,793 | -204,703 | -119,424 |
| Depreciation Amortization | 660 | 720 | 1,031 | 640 | 221 |
| Accounts receivable | -789 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,867 | -1,136 | -776 | 8,878 | 284 |
| Other Working Capital | -15,490 | 9,851 | 6,459 | 3,266 | -437 |
| Other Operating Activity | 9,502 | 4,930 | 9,559 | 106,451 | 93,736 |
| Operating Cash Flow | $-23,612 | $-47,741 | $-101,520 | $-85,469 | $-25,619 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,701 | 72,118 | N/A | N/A | N/A |
| PPE Investments | -750 | -79 | -4,405 | -3,912 | -2,292 |
| Purchase Of Investment | N/A | N/A | -116,064 | -17,959 | -16,337 |
| Sale Of Investment | N/A | N/A | 34,226 | 20,076 | 19,132 |
| Purchase Sale Intangibles | N/A | 2,941 | N/A | -48 | -53 |
| Other Investing Activity | 0 | 2,941 | 0 | -3,543 | -53 |
| Investing Cash Flow | $-3,451 | $74,980 | $-86,243 | $-5,338 | $450 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 227 | 45 | 137 | 224,605 | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | -576 | N/A |
| Other Financing Activity | 0 | 0 | -222 | -17,605 | 140,809 |
| Financing Cash Flow | $227 | $45 | $-85 | $206,424 | $140,809 |
| Exchange Rate Effect | -595 | -568 | -858 | -6,327 | -8,190 |
| Beginning Cash Position | 105,663 | 78,947 | 267,716 | 158,426 | 47,353 |
| End Cash Position | 78,232 | 105,663 | 79,010 | 267,716 | 154,803 |
| Net Cash Flow | $-27,431 | $26,716 | $-188,706 | $109,290 | $107,450 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,612 | -47,741 | -101,520 | -85,469 | -25,619 |
| Capital Expenditure | -750 | -81 | -4,405 | -3,912 | -2,292 |
| Free Cash Flow | -24,362 | -47,822 | -105,925 | -89,381 | -27,911 |